Suppr超能文献

对持续性鸡蛋过敏的儿科患者进行特异性口服耐受诱导。

Specific oral tolerance induction in paediatric patients with persistent egg allergy.

作者信息

Fuentes-Aparicio V, Alvarez-Perea A, Infante S, Zapatero L, D'Oleo A, Alonso-Lebrero E

机构信息

Allergy Department, Hospital Materno-Infantil Gregorio Marañón, Madrid, Spain.

出版信息

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):143-50. doi: 10.1016/j.aller.2012.02.007. Epub 2012 Jul 24.

Abstract

INTRODUCTION

Desensitisation or specific oral tolerance induction (SOTI) to food is a new topical-therapeutic approach of food allergy for those children who have not achieved tolerance spontaneously. The objective of this study is to induce clinical tolerance in children with persistent allergy using an oral desensitisation protocol with powdered pasteurised egg.

METHODS

Seventy-two patients with egg allergy confirmed by open oral challenge test were randomly assigned to SOTI or elimination diet as a control group. Forty children (5-15 years) underwent a SOTI beginning with 1mg and increasing the dosage weekly until a dose of 10g, equivalent to an egg. The control group included 32 patients (4-15 years).

RESULTS

The procedure's average duration was 10 weeks (range 4-28 weeks). Three patients were withdrawn from the protocol for persistent gastrointestinal symptoms. During SOTI, 21 children (52.5%) presented symptoms. In eight the symptoms were mild and required no treatment. In the other 13 (61.90%), the reactions were more severe. Seventeen children finished the treatment over a year ago and 20 in the past 6-12 months. Thirty-seven patients (92.5%) in the active group achieved tolerance to egg, versus 21.8% in the control group. We only found statistically significant differences (p<0.05) for skin prick tests with powdered egg at various dilutions and IgG levels with egg white after SOTI. Specific IgE concentration did not change significantly.

CONCLUSIONS

Our SOTI protocol is a safe, effective treatment for food allergy and of reasonable duration, confirming that tolerance can be induced in children who have not achieved it spontaneously.

摘要

引言

对于那些未自发实现耐受的儿童,食物脱敏或特异性口服耐受诱导(SOTI)是一种治疗食物过敏的新的局部治疗方法。本研究的目的是使用巴氏杀菌鸡蛋粉口服脱敏方案诱导持续性过敏儿童产生临床耐受。

方法

通过开放性口服激发试验确诊为鸡蛋过敏的72例患者被随机分为SOTI组或作为对照组的排除饮食组。40名儿童(5 - 15岁)开始进行SOTI,起始剂量为1毫克,每周增加剂量直至达到相当于一个鸡蛋的10克剂量。对照组包括32例患者(4 - 15岁)。

结果

该过程的平均持续时间为10周(范围4 - 28周)。3例患者因持续性胃肠道症状退出该方案。在SOTI期间,21名儿童(52.5%)出现症状。其中8名症状轻微,无需治疗。在另外13名儿童(61.90%)中,反应更为严重。17名儿童在一年多前完成治疗,20名在过去6 - 12个月内完成治疗。活性组中有37例患者(92.5%)实现了对鸡蛋的耐受,而对照组为21.8%。在SOTI后,我们仅发现不同稀释度的鸡蛋粉皮肤点刺试验和蛋清IgG水平存在统计学显著差异(p<0.05)。特异性IgE浓度没有显著变化。

结论

我们的SOTI方案是一种安全、有效的食物过敏治疗方法,持续时间合理,证实了可以在未自发实现耐受的儿童中诱导出耐受。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验